bibliographic resource 2764104 [br/2764104]
https://w3id.org/oc/corpus/br/2764104

is a

• document
• article

title

• A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

publication date

• 2014-01-01

contributor

• https://w3id.org/oc/corpus/ar/10202560
• https://w3id.org/oc/corpus/ar/10202561
• https://w3id.org/oc/corpus/ar/10202562
• https://w3id.org/oc/corpus/ar/10202563
• https://w3id.org/oc/corpus/ar/10202564
• https://w3id.org/oc/corpus/ar/10202565
• https://w3id.org/oc/corpus/ar/10202566
• https://w3id.org/oc/corpus/ar/10202567
• https://w3id.org/oc/corpus/ar/10202568
• https://w3id.org/oc/corpus/ar/10202569
• https://w3id.org/oc/corpus/ar/10202570
• https://w3id.org/oc/corpus/ar/10202571
• https://w3id.org/oc/corpus/ar/10202572
• https://w3id.org/oc/corpus/ar/10202573
• https://w3id.org/oc/corpus/ar/10202574
• https://w3id.org/oc/corpus/ar/10202575
• https://w3id.org/oc/corpus/ar/10202576
• https://w3id.org/oc/corpus/ar/10202577
• https://w3id.org/oc/corpus/ar/10202578
• https://w3id.org/oc/corpus/ar/10202579
• https://w3id.org/oc/corpus/ar/10202580
• https://w3id.org/oc/corpus/ar/10202581
• https://w3id.org/oc/corpus/ar/10202582
• https://w3id.org/oc/corpus/ar/10202583
• https://w3id.org/oc/corpus/ar/10202584
• https://w3id.org/oc/corpus/ar/10202585
• https://w3id.org/oc/corpus/ar/10202586

format

• https://w3id.org/oc/corpus/re/1483595

identifier

• https://w3id.org/oc/corpus/id/5295823
• https://w3id.org/oc/corpus/id/5295824
• https://w3id.org/oc/corpus/id/5295825
• https://w3id.org/oc/corpus/id/5295826

part of

• https://w3id.org/oc/corpus/br/290066